Proportion of CD34+CD38−CD123+ Leukemia Stem Cells at Diagnosis Varies in ELN Risk Groups and an Emerging Novel Marker for Prognosticating the Intermediate Risk patients of Acute Myeloid Leukemia: A Prospective Study
2016 ◽
Vol 13
(2)
◽
pp. 248-259
◽
Keyword(s):
2009 ◽
pp. 287-300
◽
2012 ◽
2020 ◽
Keyword(s):
2019 ◽
Vol 38
(1)
◽
Keyword(s):